Dennis Winger Insider Profile
4 Followers
Dennis Winger, Director at Nektar Therapeutics, holds 47.75K shares in Nektar Therapeutics (Ticker: NKTR), holds 162.18K shares in Accuray (Ticker: ARAY), holds 4.64K shares in Pacira Pharmaceuticals (Ticker: PCRX).
Dennis Winger's Trading History
| NKTRNektar Therapeutics | Aug 21, 2018 | Director | Uninformative Buy | 427.80K | $1.78M | |
| ARAYAccuray | Dec 04, 2017 | Director | Uninformative Buy | ― | $454.11K | |
| PCRXPacira Pharmaceuticals | Jun 16, 2017 | Director | Uninformative Buy | ― | $169.36K | |
| VRTXVertex Pharmaceuticals | Mar 12, 2012 | Director | Uninformative Buy | 1.32M | $3.50M | |
| HRTXHeron Therapeutics | ― | Director | ― | $21.56K |
You May Also Like
Dennis Winger insider profile FAQ
What is the percentage of profitable transactions made by Dennis Winger?
The percentage of profitable transactions made by Dennis Winger is 67%.
What is the average return per transaction made by Dennis Winger?
The average return per transaction made by Dennis Winger is 36.30%.
What stocks does Dennis Winger hold?
Dennis Winger holds: NKTR, ARAY, PCRX, HRTX, VRTX stocks.
What was Dennis Winger’s latest transaction?
Dennis Winger’s latest transaction was an Uninformative Buy of $427.80K.
What was Dennis Winger's most profitable transaction?
Dennis Winger’s most profitable transaction was an Informative Sell of NKTR stock on August 21, 2018. The return on the trade was 72.50%.
What is Dennis Winger's role in Nektar Therapeutics?
Dennis Winger's role in Nektar Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
